NCT07634146Not yet recruiting
Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study
A Randomized, Sham Supplement- and Care-as-Usual-Controlled Study to Evaluate Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study
Source: ClinicalTrials.gov · Last updated 8 Jun 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 920 (estimated)
- First submitted
- 26 May 2026
- Start date
- 8 Jul 2026
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- Miracle Wellness LLC
- Diseases
- Migraine
- NCT number
- NCT07634146
What you commit to
- Study type: Interventional
- Planned participants: 920
- From 8 Jul 2026 to the primary completion date, 30 Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of overlapping supplements or interacting medications.
- Daily use of alcohol, tobacco, or recreational drugs.
- Participation in any other clinical or interventional study within 30 days prior to baseline or concurrently.
Other illness
- Presence of any active medical condition or diagnosis other than episodic migraine, including liver or kidney disease or condition.
- Known allergies to study ingredients.
Other
- Pregnancy or lactation.
Who the study is looking for
- Self-reported history of migraine, based on the International Headache Society (IHS) International Classification of Headache Disorders, 3rd edition (ICHD-3) diagnostic criteria for migraine.
- Being able to take oral supplements.
- Agreeing to maintain their regular lifestyle.
- Access to internet and telephone.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Natural Migraceuticals Coordinator of this site? Confirm its status | Lutherville-Timonium | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.